Isolated monoclonal antibodies and/or antigen-binding fragments thereof against indoxyl sulfate and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11560423
APP PUB NO 20200308263A1
SERIAL NO

16902006

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to isolated monoclonal antibodies (mAbs) and/or antigen-binding fragments thereof that specifically recognize indoxyl sulfate, a protein-bound uremic toxin, and uses of such isolated anti-IS mAbs and/or antigen-binding fragments thereof to create immunoassay methods applied in theragnosis of IS-related diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LEADGENE BIOMEDICAL INCNO 9 LN 147 ZHENGBEI 1ST RD YONGKANG DIST TAINAN CITY 710

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheng, Yu-Wei Tainan, TW 14 30
Chuang, Yung-Chun Tainan, TW 21 31
Kao, Chih-Hui Tainan, TW 3 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 24, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 24, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 24, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00